While the anti-cancer activity of EQW has not yet been determined, ERK1/2 inhibitor Cedrelone identified in this study binds to similar binding pocket in ERK1/2 as does EQW, resulting in inhibition of the ERK1/2 phosphorylation. This evidence concerns the gene MAPK3 and cancer.